178 related articles for article (PubMed ID: 35639708)
1. Target and drug predictions for SARS-CoV-2 infection in hepatocellular carcinoma patients.
Wang L; Ding Y; Zhang C; Chen R
PLoS One; 2022; 17(5):e0269249. PubMed ID: 35639708
[TBL] [Abstract][Full Text] [Related]
2. Network-based identification genetic effect of SARS-CoV-2 infections to Idiopathic pulmonary fibrosis (IPF) patients.
Taz TA; Ahmed K; Paul BK; Kawsar M; Aktar N; Mahmud SMH; Moni MA
Brief Bioinform; 2021 Mar; 22(2):1254-1266. PubMed ID: 33024988
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive DNA methylation profiling of COVID-19 and hepatocellular carcinoma to identify common pathogenesis and potential therapeutic targets.
Luo H; Chen J; Jiang Q; Yu Y; Yang M; Luo Y; Wang X
Clin Epigenetics; 2023 Jun; 15(1):100. PubMed ID: 37309005
[TBL] [Abstract][Full Text] [Related]
4. Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic.
Hasankhani A; Bahrami A; Sheybani N; Aria B; Hemati B; Fatehi F; Ghaem Maghami Farahani H; Javanmard G; Rezaee M; Kastelic JP; Barkema HW
Front Immunol; 2021; 12():789317. PubMed ID: 34975885
[TBL] [Abstract][Full Text] [Related]
5. Potential core genes associated with COVID-19 identified via weighted gene co-expression network analysis.
Wu C; Wu Z; Chen Y; Huang X; Tian B
Swiss Med Wkly; 2022 Nov; 152():40033. PubMed ID: 36509426
[TBL] [Abstract][Full Text] [Related]
6. Integrated Analysis of Bulk RNA-Seq and Single-Cell RNA-Seq Unravels the Influences of SARS-CoV-2 Infections to Cancer Patients.
Chen Y; Qin Y; Fu Y; Gao Z; Deng Y
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555339
[TBL] [Abstract][Full Text] [Related]
7. Identification of common molecular signatures of SARS-CoV-2 infection and its influence on acute kidney injury and chronic kidney disease.
Zhang W; Liu L; Xiao X; Zhou H; Peng Z; Wang W; Huang L; Xie Y; Xu H; Tao L; Nie W; Yuan X; Liu F; Yuan Q
Front Immunol; 2023; 14():961642. PubMed ID: 37026010
[TBL] [Abstract][Full Text] [Related]
8. Microarray Data Mining and Preliminary Bioinformatics Analysis of Hepatitis D Virus-Associated Hepatocellular Carcinoma.
Yu Z; Ma X; Zhang W; Chang X; An L; Niu M; Chen Y; Sun C; Yang Y
Biomed Res Int; 2021; 2021():1093702. PubMed ID: 33564675
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatics and system biology approach to identify the influences of SARS-CoV-2 infections to idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease patients.
Mahmud SMH; Al-Mustanjid M; Akter F; Rahman MS; Ahmed K; Rahman MH; Chen W; Moni MA
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33847347
[TBL] [Abstract][Full Text] [Related]
10. Differential gene expression profiling reveals potential biomarkers and pharmacological compounds against SARS-CoV-2: Insights from machine learning and bioinformatics approaches.
Hoque MN; Sarkar MMH; Khan MA; Hossain MA; Hasan MI; Rahman MH; Habib MA; Akter S; Banu TA; Goswami B; Jahan I; Nafisa T; Molla MMA; Soliman ME; Araf Y; Khan MS; Zheng C; Islam T
Front Immunol; 2022; 13():918692. PubMed ID: 36059456
[TBL] [Abstract][Full Text] [Related]
11. Identification of SARS-CoV-2 Proteins Binding Human mRNAs As a Novel Signature Predicting Overall Survival in Hepatocellular Carcinoma.
Chen S
DNA Cell Biol; 2021 Feb; 40(2):359-372. PubMed ID: 33290144
[TBL] [Abstract][Full Text] [Related]
12. Identification of Potential Hub Genes Related to Diagnosis and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma via Integrated Bioinformatics Analysis.
Tang Y; Zhang Y; Hu X
Biomed Res Int; 2020; 2020():4251761. PubMed ID: 33376723
[TBL] [Abstract][Full Text] [Related]
13. Identification of biomarkers and pathways for the SARS-CoV-2 infections that make complexities in pulmonary arterial hypertension patients.
Taz TA; Ahmed K; Paul BK; Al-Zahrani FA; Mahmud SMH; Moni MA
Brief Bioinform; 2021 Mar; 22(2):1451-1465. PubMed ID: 33611340
[TBL] [Abstract][Full Text] [Related]
14. Identification and interaction analysis of key genes and microRNAs in hepatocellular carcinoma by bioinformatics analysis.
Mou T; Zhu D; Wei X; Li T; Zheng D; Pu J; Guo Z; Wu Z
World J Surg Oncol; 2017 Mar; 15(1):63. PubMed ID: 28302149
[TBL] [Abstract][Full Text] [Related]
15. Identifying potential pharmacological targets and mechanisms of vitamin D for hepatocellular carcinoma and COVID-19.
Huang Y; Yuan Y; Chen S; Xu D; Xiao L; Wang X; Qin W; Liu B
Front Immunol; 2022; 13():985781. PubMed ID: 36275701
[TBL] [Abstract][Full Text] [Related]
16. Blood transcriptome analysis revealed the crosstalk between COVID-19 and HIV.
Yan C; Niu Y; Wang X
Front Immunol; 2022; 13():1008653. PubMed ID: 36389792
[TBL] [Abstract][Full Text] [Related]
17. Identification of potential transcription factors, long noncoding RNAs, and microRNAs associated with hepatocellular carcinoma.
Yan H; Wang Q; Shen Q; Li Z; Tian J; Jiang Q; Gao L
J Cancer Res Ther; 2018 Sep; 14(Supplement):S622-S627. PubMed ID: 30249878
[TBL] [Abstract][Full Text] [Related]
18. Bioinformatics analysis of key biomarkers and potential molecular mechanisms in hepatocellular carcinoma induced by hepatitis B virus.
Li Z; Xu J; Cui H; Song J; Chen J; Wei J
Medicine (Baltimore); 2020 May; 99(20):e20302. PubMed ID: 32443377
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis to identify the influences of SARS-CoV-2 infections to inflammatory bowel disease.
Zhang C; Ma Z; Nan X; Wang W; Zeng X; Chen J; Cai Z; Wang J
Front Immunol; 2023; 14():1024041. PubMed ID: 36817436
[TBL] [Abstract][Full Text] [Related]
20. Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC.
Lou W; Liu J; Ding B; Chen D; Xu L; Ding J; Jiang D; Zhou L; Zheng S; Fan W
J Transl Med; 2019 Jan; 17(1):7. PubMed ID: 30602391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
